Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AAREYDRUGS.NSthis companyAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
BRBROOKS.BOBrooks Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BROOKS.NSBrooks Laboratories Limited	₹65.75	4.44×	0.89×	1.27×	4.08×	-153.4%	21.0%	6.4%	28.7%	20.0%	4.1%	4.7%	0.07×	0.04×	6.55×	1.72×	0.0%	4	—	2	B-
NENECLIFE.BONectar Lifesciences Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
NECLIFE.NSNectar Lifesciences Limited	₹10.25	-0.67×	0.34×	97.56×	-2.9×	-45.1%	-2936.3%	-95.1%	-14568.1%	-50.3%	-0.2%	-184.1%	0×	3.87×	-0.05×	8.4×	0.0%	3	—	2	C+
Peer median	—	4.44×	0.89×	1.72×	4.08×	-102.8%	13.4%	6.4%	7.4%	11.5%	4.1%	-5.1%	0.07×	1.71×	2.7×	1.72×	0.0%	4	—	2	—